- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 287803, 11 pages
Immunomodulatory Activity of Lactococcus lactis A17 from Taiwan Fermented Cabbage in OVA-Sensitized BALB/c Mice
1Department of Science Education, National Taipei University of Education, 134, Section 2, Heping E. Road, Da-an District, Taipei 10671, Taiwan
2Institute of Biochemistry and Molecular Biology, National Yang-Ming University, 155, Section 2, Linong Street, Taipei 11221, Taiwan
3Asian Probiotics and Prebiotics Corporation, Room 9B, No. 6-8 Lane 511, Wuzhong Road, Minhang District, Shanghai, China
4GINCARE Int'l Enterprises Co., Ltd., No. 24, Section 3, Chungyang Road, Tu-Cheng District, New Taipei City 23673, Taiwan
Received 24 October 2012; Accepted 17 December 2012
Academic Editor: Jae Youl Cho
Copyright © 2013 Hui-Ching Mei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- R. Bibiloni, R. N. Fedorak, G. W. Tannock et al., “VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis,” The American Journal of Gastroenterology, vol. 100, no. 7, pp. 1539–1546, 2005.
- S. Rakoff-Nahoum, J. Paglino, F. Eslami-Varzaneh, S. Edberg, and R. Medzhitov, “Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis,” Cell, vol. 118, no. 2, pp. 229–241, 2004.
- J. Ezendam and H. van Loveren, “Probiotics: immunomodulation and evaluation of safety and efficacy,” Nutrition Reviews, vol. 64, no. 1, pp. 1–14, 2006.
- D. Fujiwara, S. Inoue, H. Wakabayashi, and T. Fujii, “The anti-allergic effects of lactic acid bacteria are strain dependent and mediated by effects on both Th1/Th2 cytokine expression and balance,” International Archives of Allergy and Immunology, vol. 135, no. 3, pp. 205–215, 2004.
- L. E. M. Niers, H. M. Timmerman, G. T. Rijkers et al., “Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines,” Clinical and Experimental Allergy, vol. 35, no. 11, pp. 1481–1489, 2005.
- J. Wassenberg, S. Nutten, R. Audran et al., “Effect of Lactobacillus paracasei ST11 on a nasal provocation test with grass pollen in allergic rhinitis,” Clinical and Experimental Allergy, vol. 41, no. 4, pp. 565–573, 2011.
- T. J. Won, B. Kim, Y. T. Lim et al., “Oral administration of Lactobacillus strains from Kimchi inhibits atopic dermatitis in NC/Nga mice,” Journal of Applied Microbiology, vol. 110, no. 5, pp. 1195–1202, 2011.
- W. Eder, M. J. Ege, and E. von Mutius, “The asthma epidemic,” The New England Journal of Medicine, vol. 355, no. 21, pp. 2226–2235, 2006.
- M. Morisset, C. Aubert-Jacquin, P. Soulaines, D. A. Moneret-Vautrin, and C. Dupont, “A non-hydrolyzed, fermented milk formula reduces digestive and respiratory events in infants at high risk of allergy,” European Journal of Clinical Nutrition, vol. 65, no. 2, pp. 175–183, 2011.
- T. A. E. Platts-Mills, “The role of immunoglobulin E in allergy and asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 8, part 2, pp. S1–S5, 2001.
- T. Morokata, J. Ishikawa, K. Ida, and T. Yamada, “C57BL/6 mice are more susceptible to antigen-induced pulmonary eosinophilia than BALB/c mice, irrespective of systemic T helper 1/T helper 2 responses,” Immunology, vol. 98, no. 3, pp. 345–351, 1999.
- M. Kalliomäki, S. Salminen, H. Arvilommi, P. Kero, P. Koskinen, and E. Isolauri, “Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial,” The Lancet, vol. 357, no. 9262, pp. 1076–1079, 2001.
- M. Kalliomäki, S. Salminen, T. Poussa, H. Arvilommi, and E. Isolauri, “Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial,” The Lancet, vol. 361, no. 9372, pp. 1869–1871, 2003.
- K. Shida, K. Makino, A. Morishita et al., “Lactobacillus casei inhibits antigen-induced IgE secretion through regulation of cytokine production in murine splenocyte cultures,” International Archives of Allergy and Immunology, vol. 115, no. 4, pp. 278–287, 1998.
- K. Shida, R. Takahashi, E. Iwadate et al., “Lactobacillus casei strain Shirota suppresses serum immunoglobulin E and immunoglobulin G1 responses and systemic anaphylaxis in a food allergy model,” Clinical and Experimental Allergy, vol. 32, no. 4, pp. 563–570, 2002.
- Y. Inoue, N. Iwabuchi, J. Z. Xiao, T. Yaeshima, and K. Iwatsuki, “Suppressive effects of Bifidobacterium breve strain M-16V on T-helper type 2 immune responses in a murine model,” Biological and Pharmaceutical Bulletin, vol. 32, no. 4, pp. 760–763, 2009.
- Y. G. Kim, J. H. Park, M. H. Shaw, L. Franchi, N. Inohara, and G. Núñez, “The cytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defense after exposure to toll-like receptor ligands,” Immunity, vol. 28, no. 2, pp. 246–257, 2008.
- J. R. Li and Y. H. P. Hsieh, “Traditional Chinese food technology and cuisine,” Asia Pacific Journal of Clinical Nutrition, vol. 13, no. 2, pp. 147–155, 2004.
- S. H. Chao, Y. Tomii, K. Watanabe, and Y. C. Tsai, “Diversity of lactic acid bacteria in fermented brines used to make stinky tofu,” International Journal of Food Microbiology, vol. 123, no. 1-2, pp. 134–141, 2008.
- S. H. Chao, R. J. Wu, K. Watanabe, and Y. C. Tsai, “Diversity of lactic acid bacteria in suan-tsai and fu-tsai, traditional fermented mustard products of Taiwan,” International Journal of Food Microbiology, vol. 135, no. 3, pp. 203–210, 2009.
- Y. W. Liu, J. C. Liu, C. Y. Huang, C. K. Wang, H. F. Shang, and W. C. Hou, “Effects of oral administration of yam tuber storage protein, dioscorin, to BALB/c mice for 21-days on immune responses,” Journal of Agricultural and Food Chemistry, vol. 57, no. 19, pp. 9274–9279, 2009.
- T. Matsuzaki, “Immunomodulation by treatment with Lactobacillus casei strain Shirota,” International Journal of Food Microbiology, vol. 41, no. 2, pp. 133–140, 1998.
- Y. W. Liu, H. F. Shang, C. K. Wang, F. L. Hsu, and W. C. Hou, “Immunomodulatory activity of dioscorin, the storage protein of yam (Dioscorea alata cv. Tainong No. 1) tuber,” Food and Chemical Toxicology, vol. 45, no. 11, pp. 2312–2318, 2007.
- Y. Sato, H. Akiyama, H. Suganuma et al., “The feeding of β-carotene down-regulates serum IgE levels and inhibits the type I allergic response in mice,” Biological and Pharmaceutical Bulletin, vol. 27, no. 7, pp. 978–984, 2004.
- Y. W. Liu, Y. W. Su, W. K. Ong, T. H. Cheng, and Y. C. Tsai, “Oral administration of Lactobacillus plantarum K68 ameliorates DSS-induced ulcerative colitis in BALB/c mice via the anti-inflammatory and immunomodulatory activities,” International Immunopharmacology, vol. 11, no. 12, pp. 2159–2166, 2011.
- H. Yasui, J. Kiyoshima, and T. Hori, “Reduction of influenza virus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota,” Clinical and Diagnostic Laboratory Immunology, vol. 11, no. 4, pp. 675–679, 2004.
- C. C. Chen, W. C. Lin, M. S. Kong, et al., “Oral inoculation of probiotics Lactobacillus acidophilus NCFM suppresses tumour growth both in segmental orthotopic colon cancer and extra-intestinal tissue,” The British Journal of Nutrition, vol. 30, pp. 1–12, 2011.
- L. G. Bermúdez-Humarán, N. G. Cortes-Perez, F. Lefèvre et al., “A novel mucosal vaccine based on live lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors,” Journal of Immunology, vol. 175, no. 11, pp. 7297–7302, 2005.
- A. Miyoshi, I. Poquet, V. Azevedo et al., “Controlled production of stable heterologous proteins in Lactococcus lactis,” Applied and Environmental Microbiology, vol. 68, no. 6, pp. 3141–3146, 2002.
- M. Bahey-El-Din, C. G. M. Gahan, and B. T. Griffin, “Lactococcus lactis as a cell factory for delivery of therapeutic proteins,” Current Gene Therapy, vol. 10, no. 1, pp. 34–45, 2010.
- N. G. Cortes-Perez, S. Ah-Leung, L. G. Bermúdez-Humarán et al., “Intranasal coadministration of live lactococci producing interleukin-12 and a major cow's milk allergen inhibits allergic reaction in mice,” Clinical and Vaccine Immunology, vol. 14, no. 3, pp. 226–233, 2007.
- B. Marelli, A. R. Perez, C. Banchio, D. de Mendoza, and C. Magni, “Oral immunization with live Lactococcus lactis expressing rotavirus VP8* subunit induces specific immune response in mice,” Journal of Virological Methods, vol. 175, no. 1, pp. 28–37, 2011.
- J. Debarry, H. Garn, A. Hanuszkiewicz et al., “Acinetobacter lwoffii and Lactococcus lactis strains isolated from farm cowsheds possess strong allergy-protective properties,” The Journal of Allergy and Clinical Immunology, vol. 119, no. 6, pp. 1514–1521, 2007.
- P. Rupa, J. Schmied, and B. N. Wilkie, “Prophylaxis of experimentally induced ovomucoid allergy in neonatal pigs using Lactococcus lactis,” Veterinary immunology and immunopathology, vol. 140, no. 1-2, pp. 23–29, 2011.
- K. Shida, J. Kiyoshima-Shibata, M. Nagaoka, K. Watanabe, and M. Nanno, “Induction of interleukin-12 by Lactobacillus strains having a rigid cell wall resistant to intracellular digestion,” Journal of Dairy Science, vol. 89, no. 9, pp. 3306–3317, 2006.
- A. Inamine, D. Sakurai, S. Horiguchi, et al., “Sublingual administration of Lactobacillus paracasei KW3110 inhibits Th2-dependent allergic responses via upregulation of PD-L2 on dendritic cells,” Clinical Immunology, vol. 143, no. 2, pp. 170–179, 2012.
- J. D. Greene and T. R. Klaenhammer, “Factors involved in adherence of lactobacilli to human Caco-2 cells,” Applied and Environmental Microbiology, vol. 60, no. 12, pp. 4487–4494, 1994.
- A. C. Ouwehand, E. Isolauri, P. V. Kirjavainen, and S. J. Salminen, “Adhesion of four Bifidobacterium strains to human intestinal mucus from subjects in different age groups,” FEMS Microbiology Letters, vol. 172, no. 1, pp. 61–64, 1999.
- E. J. Schiffrin, D. Brassart, A. L. Servin, F. Rochat, and A. Donnet-Hughes, “Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection,” The American Journal of Clinical Nutrition, vol. 66, no. 2, pp. 515S–520S, 1997.
- Y. Nonaka, T. Izumo, F. Izumi et al., “Antiallergic effects of Lactobacillus pentosus strain S-PT84 mediated by modulation of Th1/Th2 immunobalance and induction of IL-10 production,” International Archives of Allergy and Immunology, vol. 145, no. 3, pp. 249–257, 2008.
- A. Yoshida, R. Aoki, H. Kimoto-Nira et al., “Oral administration of live Lactococcus lactis C59 suppresses IgE antibody production in ovalbumin-sensitized mice via the regulation of interleukin-4 production,” FEMS Immunology and Medical Microbiology, vol. 61, no. 3, pp. 315–322, 2011.
- E. Meylan, J. Tschopp, and M. Karin, “Intracellular pattern recognition receptors in the host response,” Nature, vol. 442, no. 7098, pp. 39–44, 2006.
- K. Takeda, T. Kaisho, and S. Akira, “Toll-like receptors,” Annual Review of Immunology, vol. 21, pp. 335–376, 2003.
- W. Duan, A. K. Mehta, J. G. Magalhaes et al., “Innate signals from Nod2 block respiratory tolerance and program TH2-driven allergic inflammation,” Journal of Allergy and Clinical Immunology, vol. 126, no. 6, pp. 1284.e10–1293.e10, 2010.
- J. G. Magalhaes, S. J. Rubino, L. H. Travassos, et al., “Nucleotide oligomerization domain-containing proteins instruct T cell helper type 2 immunity through stromal activation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 36, pp. 14896–14901, 2011.
- S. C. Eisenbarth, D. A. Piggott, J. W. Huleatt, I. Visintin, C. A. Herrick, and K. Bottomly, “Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen,” The Journal of Experimental Medicine, vol. 196, no. 12, pp. 1645–1651, 2002.
- V. Redecke, H. Häcker, S. K. Datta et al., “Cutting edge: activation of toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma,” Journal of Immunology, vol. 172, no. 5, pp. 2739–2743, 2004.
- M. Schnare, G. M. Barton, A. C. Holt, K. Takeda, S. Akira, and R. Medzhitov, “Toll-like receptors control activation of adaptive immune responses,” Nature Immunology, vol. 2, no. 10, pp. 947–950, 2001.
- C. A. Salkowski, G. R. Detore, and S. N. Vogel, “Lipopolysaccharide and monophosphoryl lipid A differentially regulate interleukin-12, gamma interferon, and interleukin-10 mRNA production in murine macrophages,” Infection and Immunity, vol. 65, no. 8, pp. 3239–3247, 1997.
- A. Yoshida and Y. Koide, “Arabinofuranosyl-terminated and mannosylated lipoarabinomannans from Mycobacterium tuberculosis induce different levels of interleukin-12 expression in murine macrophages,” Infection and Immunity, vol. 65, no. 5, pp. 1953–1955, 1997.
- M. G. Cleveland, J. D. Gorham, T. L. Murphy, E. Tuomanen, and K. M. Murphy, “Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway,” Infection and Immunity, vol. 64, no. 6, pp. 1906–1912, 1996.
- E. Lien, T. J. Sellati, A. Yoshimura et al., “Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products,” The Journal of Biological Chemistry, vol. 274, no. 47, pp. 33419–33425, 1999.
- M. D. Halpern, R. J. Kurlander, and D. S. Pisetsky, “Bacterial DNA induces murine interferon- production by stimulation of interleukin-12 and tumor necrosis factor-,” Cellular Immunology, vol. 167, no. 1, pp. 72–78, 1996.
- K. Takeda and S. Akira, “Toll-like receptors in innate immunity,” International Immunology, vol. 17, no. 1, pp. 1–14, 2005.
- Y. H. Ryu, J. E. Baik, J. S. Yang et al., “Differential immunostimulatory effects of Gram-positive bacteria due to their lipoteichoic acids,” International Immunopharmacology, vol. 9, no. 1, pp. 127–133, 2009.
- T. Sashihara, N. Sueki, and S. Ikegami, “An analysis of the effectiveness of heat-killed lactic acid bacteria in alleviating allergic diseases,” Journal of Dairy Science, vol. 89, no. 8, pp. 2846–2855, 2006.
- C. C. Ou, S. L. Lin, J. J. Tsai, and M. Y. Lin, “Heat-killed lactic acid bacteria enhance immunomodulatory potential by skewing the immune response toward Th1 polarization,” Journal of Food Science, vol. 76, no. 5, pp. M260–M267, 2011.